
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
王亚明, 顾维乐. 疏肝益精汤联合激光治疗中心性浆液性脉络膜视网膜病变[J]. 中国实验方剂学杂志, 2012,18(14):278-280.
WANG Ya-ming, GU Wei-le. Clinical Observation on Shugan Yijing Decoction Combining with Laser in Treatment of Central Serous Retinopathy[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(14): 278-280.
王亚明, 顾维乐. 疏肝益精汤联合激光治疗中心性浆液性脉络膜视网膜病变[J]. 中国实验方剂学杂志, 2012,18(14):278-280. DOI:
WANG Ya-ming, GU Wei-le. Clinical Observation on Shugan Yijing Decoction Combining with Laser in Treatment of Central Serous Retinopathy[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(14): 278-280. DOI:
目的: 探讨疏肝益精汤联合激光治疗中心性浆液性脉络膜视网膜病变的疗效。 方法: 回顾性分析了2010年1月到2011年12月期间在山东省青岛市黄岛区中医医院治疗的中心性浆液性脉络膜视网膜病变患者126例患者随机分为两组
治疗组(62例)和对照组(64例)
治疗组给予疏肝益精汤联合激光治疗
对照组给予传统药物口服治疗
疗程均为30 d。以患者最佳矫正视力及平均光敏感度为观察指标。 结果: 治疗后1个月
与对照组比较
治疗组视力改善程度
平均光敏感度均比对照组显著好转
差异显著
有统计学意义(P<0.05)。 结论: 疏肝益精汤联合激光治疗中心性浆液性脉络膜视网膜病变
能保护黄斑的视功能
安全有效。
Objective: To observe the efficiency of Shugan Yijing decoction combining with laser in treatment of central serous retinopathy. Method: A retrospective analysis on the one hundred and twenty-six patients with central serous retinopathy in our hospital from January 2010 to December 2011
the 126 cases were randomly divided into two groups: treatment group (n=62) and the control group (n=64)
the treatment group was treated with Shugan Yijing decoction combining with laser treatment
the control group was treated with traditional treatment
the treatment course was 30 d. The best corrected visual acuity and average light sensitivity index were observed. Result: After treatment
compared with control group
in treatment group the visual acuity was increased
average light sensitivity was better than that in control group
the difference was statistically significant (P<0.05). Conclusion: Shugan Yijing decoction combining with laser treatment can protect the abnormal visual function with safety and efficiency.
0
浏览量
2
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621